Overview of Dr. Bochner
Dr. Bernard Bochner is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 27 years. Dr. Bochner accepts several types of health insurance, listed below. He is one of 73 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology, 1992 - 1996- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1990 - 1992
David Geffen School of Medicine at UCLAClass of 1990
Certifications & Licensure
CA State Medical License 1991 - Present
NJ State Medical License 2021 - 2025
NY State Medical License 2000 - 2025
NC State Medical License 2021 - 2022- American Board of Urology Urology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Quality of Life in Patients Undergoing Total Pelvic Exenteration Start of enrollment: 2005 Jan 01
- Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging Start of enrollment: 2004 Jun 01
- Quality of Life in Patients With Bladder Cancer Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 260 citationsGenomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.Bastien Nguyen, Christopher Fong, Anisha Luthra, Shaleigh A Smith, Renzo G DiNatale
Cell. 2022-02-03 - 436 citationsSomatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial CarcinomaEliezer M. Van Allen, Kent W. Mouw, Philip H. Kim, Gopa Iyer, Nikhil Wagle
Cancer Discovery. 2014-08-05 - 185 citationsDNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma.Min Yuen Teo, Richard Martin Bambury, Emily C. Zabor, Emmet Jordan, Hikmat Al-Ahmadie
Clinical Cancer Research. 2017-01-30
Authored Content
- Postchemotherapy Surgery for Advanced Urothelial Cancer: Another Tool to Improve OutcomeDecember 2017
Press Mentions
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as DoctorOctober 31st, 2024- Radical Cystectomy Found Not to Substantially Diminish Quality of LifeNovember 2nd, 2021
Routine PET/CT Not Beneficial for Node-Negative PatientsApril 22nd, 2019- Join now to see all
Professional Memberships
- Member
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
